Rigel Pharmaceuticals Inc (RIGL)

Operating Cash Flow (Statement)

$30.65M

Quarterly · Period ending: · USD

RIGL logo

RIGL Operating Cash Flow (Statement)

Latest reported$30.65M
RIGL Quarterly Cash from Operations (-$4.91M → $30.65M)
High-resolution chart · PNG

RIGL operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-5,400,000
-4,913,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.